4DMedical Limited (ASX: 4DX)

4DMedical Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 17, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	234	213	231	174	361	-
Market Cap Growth	-7.71%	-7.71%	33.09%	-51.84%	-	-
Enterprise Value	209	170	191	115	318	-
Last Close Price	0.57	0.52	0.67	0.59	1.23	-
PS Ratio	56.25	56.84	321.80	164.80	1662.62	-
PB Ratio	3.30	3.01	3.24	2.92	4.33	-
P/TBV Ratio	81.56	81.56	3.28	2.97	4.36	-
EV/Sales Ratio	55.65	45.30	266.08	108.94	1467.87	-
Debt / Equity Ratio	0.07	0.07	0.07	0.10	0.02	-1.53
Asset Turnover	0.04	0.04	0.01	0.01	0.00	0.10
Inventory Turnover	0.29	0.29	0.10	9.99	1.08	3.48
Quick Ratio	1.67	1.67	4.73	6.01	10.39	0.38
Current Ratio	1.78	1.78	4.86	6.16	10.51	0.40
Return on Equity (ROE)	-50.54%	-50.54%	-48.04%	-34.43%	-59.88%	-
Return on Assets (ROA)	-26.95%	-26.95%	-33.31%	-27.52%	-28.05%	-80.30%
Return on Capital (ROIC)	-37.59%	-37.59%	-39.14%	-30.46%	-33.32%	-144.55%
Earnings Yield	-19.30%	-16.86%	-13.60%	-14.15%	-5.94%	-
FCF Yield	-13.23%	-14.54%	-9.98%	-16.07%	-4.18%	-
Buyback Yield / Dilution	-23.49%	-23.49%	5.59%	-12.14%	-92.94%	-10.54%
Total Shareholder Return	-23.49%	-23.49%	5.59%	-12.14%	-92.94%	-10.54%

Source: S&P Capital IQ. Standard template. Financial Sources.